FDA Determines Patent Review Period for LIMFLOW SYSTEM Device

You might care about this because the Food and Drug Administration, also known as the FDA, has officially determined how long a medical device called LIMFLOW SYSTEM was under regulatory review. This information is very important for the company, LimFlow GmbH, because it helps decide how long they can extend the patents for this device. The LIMFLOW SYSTEM is a medical device designed for people who have severe, ongoing blood flow problems in their limbs. This condition is known as chronic limb-threatening ischemia. These are patients who cannot have other surgeries or treatments and are at a high risk of losing a limb. The FDA's announcement is part of a special process set up by a law from 1984. This law allows patents for certain products, like medical devices, to be extended for up to five years. This can happen if the product went through a thorough FDA review before it was sold to the public. The total review period for LIMFLOW SYSTEM, as calculated by the FDA, was 2,337 days. This period is split into two main parts: a testing phase and an approval phase. The testing phase involved clinical investigations and the approval phase was when the FDA reviewed the marketing application. The FDA's specific job here is to calculate this total review time. The actual patent extension is then decided by the U.S. Patent and Trademark Office, which applies its own specific rules and limits. This notice also tells the public that they can submit comments if they think any of the dates are wrong or if they believe the company did not act quickly enough during the review process. This determination by the FDA is particularly interesting because it shows how different government agencies work together to support new medical ideas. The FDA makes sure new medical devices such as the LIMFLOW SYSTEM are safe and effective for people to use. Once a device is approved, the U.S. Patent and Trademark Office then manages patent extensions. This system helps companies get more time to exclusively sell their inventions. This extra time encourages them to invest more money and effort into research and development. For medical devices, this longer patent protection can mean more resources are available for making the device better, finding new uses for it, or making it available to more patients. Without this system, companies might not be as willing to spend the large amounts of money and time needed to get a new medical device through all the necessary trials and approvals. This notice is a clear step in that process. It highlights the FDA's careful role in tracking every part of a device's journey from early testing to market approval. It also provides a way for the public to share their thoughts. This helps make sure the process is fair and accurate. It is a good example of how regulations try to balance the need for new ideas with keeping people safe and healthy. Many different groups would find this legal document interesting. First, medical device manufacturers and companies like LimFlow GmbH are directly affected by this. They need to understand the rules for patent extensions to plan their business strategies and protect their investments in new research. Patent lawyers and experts in intellectual property would also be very interested. This notice provides specific details and timelines for how patents can be extended. Anyone involved in medical device development, from researchers to people who invest money, would want to know how these review periods are calculated. Patients and groups that support patients, especially those dealing with chronic limb-threatening ischemia, might find it relevant. This is because it relates to how available and how developed treatments for their condition will be in the future. Finally, professionals who work to get medical products approved, known as regulatory affairs professionals, would use this as a guide. It helps them understand the FDA's process for figuring out regulatory review periods. It offers a practical example of how the system works for a specific and important medical device.